DARPA: Fieldable Solutions for Hemorrhage with Bio-Artificial Resuscitation Products (FSHARP)
| קרן | US Department of Defense |
|---|---|
| מדינה | U.S.A. |
| סוג | Research Grants |
| תאריך אחרון | 10/08/2021 |
| פקולטה | Engineering, Exact Sciences, Life Sciences, Medicine |
| תיאור |
The goal of the FSHARP program is to leverage advances in bio-artificial blood substitute technologies to develop field deployable, shelf-stable hemorrhage countermeasures to sustain warfighters and civilian casualties in austere, pre-hospital settings.
TA1: Blood Substitute Development TA2: Manufacturing and Stabilization TA3: IND Submission (optional)
Funding: No fixed limit Duration 4 years (+1 year for TA3)
Research Authority due date: 15.6.21 Abstract (strongly encouraged) due date: 22.6.21 Full proposal due date: 10.8.21 |
| קבצים מצורפים | |
| קישור | לאתר |
| עדכון אחרון | עדכון אחרון: 30/05/2021 |
